Literature DB >> 14368870

Chlorpromazine in obsessive-compulsive and allied disorders.

W H TRETHOWAN, P A SCOTT.   

Abstract

Entities:  

Keywords:  CHLORPROMAZINE/therapeutic use; MENTAL DISORDERS/therapy; NEUROSES, OBSESSIVE COMPULSIVE/therapy

Mesh：

Substances：

Year:  1955        PMID： 14368870     DOI： 10.1016/s0140-6736(55)90483-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  A preliminary report on the lack of toxicity of a preparation of tatal Rauwolfia alkaloids.

Authors:  H M COLABAWALLA
Journal:  J Neurol Neurosurg Psychiatry       Date:  1958-08       Impact factor: 10.154

Review 2.  Serotonin selectivity for obsessive compulsive and panic disorders.

Authors:  S A Montgomery; T Bullock; N Fineberg
Journal:  J Psychiatry Neurosci       Date:  1991-07       Impact factor: 6.186

Review 3.  A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder.

Authors:  L L Carpenter; C J McDougle; C N Epperson; L H Price
Journal:  Drug Saf       Date:  1996-08       Impact factor: 5.606

Review 4.  Obsessive-compulsive disorder in elderly patients.

Authors:  C W Jackson
Journal:  Drugs Aging       Date:  1995-12       Impact factor: 3.923

Review 5.  Pharmacotherapeutic Strategies and New Targets in OCD.

Authors:  Christopher Pittenger
Journal:  Curr Top Behav Neurosci       Date:  2021

Review 6.  Medications that cause weight gain and alternatives in Canada: a narrative review.

Authors:  Sean Wharton; Lilian Raiber; Kristin J Serodio; Jasmine Lee; Rebecca Ag Christensen
Journal:  Diabetes Metab Syndr Obes       Date:  2018-08-21       Impact factor: 3.168
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.